Mileutis is a bio-pharmaceutical company focused on the discovery, development, and commercialization of novel and biologically sourced, safe and residual-free therapies for animal and human health. Our lead products, Imilac™ and Milac™, target the main concern in the dairy industry: the management, treatment, and prevention of mastitis in dairy cows. Mileutis’ technology and products consist of milk-derived peptides and specific protein fragments that have a positive impact on conditions that influence health and reduce antibiotic use in animal health management. Our novel therapies offer for the first time ever a non-residual, non-antibiotic solution for the biggest health issue of the dairy market. Our leading product line will not only replace antibiotics in the dairy farm but will improve cow wellbeing and provide additional and significant economic value to farmers by increasing milk yield and productivity.